Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1984 1
1995 5
1996 1
1997 2
1998 1
2000 3
2001 2
2002 2
2003 2
2004 3
2005 6
2006 3
2009 1
2011 1
2012 3
2013 6
2014 4
2015 1
2017 1
2018 2
2019 3
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: enterline ds. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models.
Parker S, McDowall C, Sanchez-Perez L, Osorio C, Duncker PC, Briley A, Swartz AM, Herndon JE 2nd, Yu YA, McLendon RE, Tedder TF, Desjardins A, Ashley DM, Gunn MD, Enterline DS, Knorr DA, Pastan IH, Nair SK, Bigner DD, Chandramohan V. Parker S, et al. Among authors: enterline ds. Sci Transl Med. 2023 Feb 8;15(682):eabn5649. doi: 10.1126/scitranslmed.abn5649. Epub 2023 Feb 8. Sci Transl Med. 2023. PMID: 36753564 Free PMC article.
Contrast Administration in CT: A Patient-Centric Approach.
Kalra MK, Becker HC, Enterline DS, Lowry CR, Molvin LZ, Singh R, Rybicki FJ. Kalra MK, et al. Among authors: enterline ds. J Am Coll Radiol. 2019 Mar;16(3):295-301. doi: 10.1016/j.jacr.2018.06.026. Epub 2018 Aug 3. J Am Coll Radiol. 2019. PMID: 30082238 Review.
CT angiography for surgical planning in face transplantation candidates.
Soga S, Pomahac B, Wake N, Schultz K, Prior RF, Kumamaru K, Steigner ML, Mitsouras D, Signorelli J, Bueno EM, Enterline DS, Rybicki FJ. Soga S, et al. Among authors: enterline ds. AJNR Am J Neuroradiol. 2013 Oct;34(10):1873-81. doi: 10.3174/ajnr.A3268. Epub 2012 Aug 9. AJNR Am J Neuroradiol. 2013. PMID: 22878008 Free PMC article. Review.
Perfusion MRI: the five most frequently asked clinical questions.
Essig M, Nguyen TB, Shiroishi MS, Saake M, Provenzale JM, Enterline DS, Anzalone N, Dörfler A, Rovira À, Wintermark M, Law M. Essig M, et al. Among authors: enterline ds. AJR Am J Roentgenol. 2013 Sep;201(3):W495-510. doi: 10.2214/AJR.12.9544. AJR Am J Roentgenol. 2013. PMID: 23971482 Free PMC article. Review.
Genetic studies in neural tube defects. NTD Collaborative Group.
Melvin EC, George TM, Worley G, Franklin A, Mackey J, Viles K, Shah N, Drake CR, Enterline DS, McLone D, Nye J, Oakes WJ, McLaughlin C, Walker ML, Peterson P, Brei T, Buran C, Aben J, Ohm B, Bermans I, Qumsiyeh M, Vance J, Pericak-Vance MA, Speer MC. Melvin EC, et al. Among authors: enterline ds. Pediatr Neurosurg. 2000 Jan;32(1):1-9. doi: 10.1159/000028889. Pediatr Neurosurg. 2000. PMID: 10765131 Review.
The eighth cranial nerve.
Enterline DS. Enterline DS. Top Magn Reson Imaging. 1996 Jun;8(3):164-79. Top Magn Reson Imaging. 1996. PMID: 8840471 Review.
54 results